Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNotes PayablesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CNBX Pharmaceuticals (CNBX) Short-term Investments (2019 - 2020)

CNBX Pharmaceuticals (CNBX) has disclosed Short-term Investments for 2 consecutive years, with $1.1 million as the latest value for Q2 2020.

  • For the quarter ending Q2 2020, Short-term Investments fell 72.07% year-over-year to $1.1 million, compared with a TTM value of $1.1 million through May 2020, down 72.07%, and an annual FY2019 reading of $3.3 million, changed N/A over the prior year.
  • Short-term Investments was $1.1 million for Q2 2020 at CNBX Pharmaceuticals, down from $1.5 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $3.9 million in Q2 2019 and bottomed at $1.1 million in Q2 2020.